Special Report | Markets in Turmoil: Amazon Death & Child Illness
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
7 Touko 202045min
Covid’s Mutations & Treatments; The (New) Office with Architectural Digest
A new report suggests that Covid-19 has mutated into a new, strong strain; former head of the FDA Dr. Scott Gottlieb explains the relationship between virus mutations and increased infectiousness. Ada...
6 Touko 202025min
Special Report | Markets in Turmoil: Pfizer Vaccine & Food Prices
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
6 Touko 202045min
Doordash CEO & the Essential Gig Economy; Reddit Co-Founder; WeWork Saga Continued
United Airlines is warning employees about job cuts after it accepted federal aid to avoid layoffs. CNBC’s Phil LeBeau reveals that this move may be just the beginning of Covid’s impact on the airline...
5 Touko 202035min
Special Report | Markets in Turmoil: Airlines & Future of Sports
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
5 Touko 202045min
Warren Buffett: “Nothing can stop America”
Berkshire Hathaway’s 2020 annual shareholder meeting, the “Woodstock for Capitalists” -- which allows the company’s 40,000+ investors to question the Oracle of Omaha directly -- was hosted virtually f...
4 Touko 202036min
Special Report | Markets in Turmoil: Gilead & COVID-19 Testing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
2 Touko 202045min
Gilead’s Remdesivir, the Drug that Could Treat Covid-19
Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and ...
1 Touko 202037min
